05.29.18
Four new omega-3 clinical abstracts from BASF will be presented at the 13th Congress of The International Society or the Study of Fatty Acids And Lipids (ISSFAL) in Las Vegas, NV, from May 27-31. The studies investigate the role and importance of a new omega-3 technology designed to deliver optimal benefits in supplements to consumers. Topics covered will be far ranging and further demonstrate the commercial potential for Accelon; from impact on cerebral blood flow, to nighttime dosing effect on EPA & DHA levels.
BASF’s recently launched Accelon omega-3 absorption technology has been shown to increase absorption of EPA and DHA at a cellular level.
“Our thought process is moving from omega-3 intake to uptake; that is, the correct absorption into the blood stream of EPA and DHA fatty acids that the body requires,” said Per-Olof Larsson, scientific affairs, omega-3 nutrition. “If an omega-3 supplement is not fully absorbed, as we now know is invariably the case, then we cannot assume every gram is getting to where it is needed. These new studies show that omega-3 absorption is arguably today’s biggest priority for scientific focus, which represents a significant change of direction for the industry.”
“These latest scientific studies are so important because they show that omega-3 enhanced with Accelon absorption technology provides optimized omega-3 benefits for consumers, added Øyvind Ihle, head of omega-3 nutrition. “Our view is that leveraging this science into compelling brand propositions provides brand owners with huge growth opportunities based on new and relevant reasons to believe. We look forward to discussing with the scientific community, key opinion leaders and brand partners how Accelon can help increase penetration and benefit the industry long term. We’re excited that BASF will once again take a lead role at ISSFAL and be the sponsor of the New Investigator Awards recognizing future research opportunities. We’re really looking forward to meeting potential candidates and partners who share our passion for omega-3 science.”
The New Investigator Awards recognize and encourage the highest standards of omega-3 research. Designed to encourage investigators at the start of their careers, application for the awards is made as part of the abstract submission system. Approximately 50 awards of complimentary registration are given, from which the best 10 applicants are selected to receive a cash award.
BASF’s recently launched Accelon omega-3 absorption technology has been shown to increase absorption of EPA and DHA at a cellular level.
“Our thought process is moving from omega-3 intake to uptake; that is, the correct absorption into the blood stream of EPA and DHA fatty acids that the body requires,” said Per-Olof Larsson, scientific affairs, omega-3 nutrition. “If an omega-3 supplement is not fully absorbed, as we now know is invariably the case, then we cannot assume every gram is getting to where it is needed. These new studies show that omega-3 absorption is arguably today’s biggest priority for scientific focus, which represents a significant change of direction for the industry.”
“These latest scientific studies are so important because they show that omega-3 enhanced with Accelon absorption technology provides optimized omega-3 benefits for consumers, added Øyvind Ihle, head of omega-3 nutrition. “Our view is that leveraging this science into compelling brand propositions provides brand owners with huge growth opportunities based on new and relevant reasons to believe. We look forward to discussing with the scientific community, key opinion leaders and brand partners how Accelon can help increase penetration and benefit the industry long term. We’re excited that BASF will once again take a lead role at ISSFAL and be the sponsor of the New Investigator Awards recognizing future research opportunities. We’re really looking forward to meeting potential candidates and partners who share our passion for omega-3 science.”
The New Investigator Awards recognize and encourage the highest standards of omega-3 research. Designed to encourage investigators at the start of their careers, application for the awards is made as part of the abstract submission system. Approximately 50 awards of complimentary registration are given, from which the best 10 applicants are selected to receive a cash award.
